Fig. 1From: Clinical outcomes and safety of polymyxin B in the treatment of carbapenem-resistant Gram-negative bacterial infections: a real-world multicenter studySurvival analysis at 28 days: Kaplan–Meier curve. Survival rate from the receiving intravenous PMB to 28 daysBack to article page